We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > generic version

News List

Mylan launches generic version of Novartis’ Exelon Patch pharmaceutical-technology
July 12, 2018
Mylan has launched Rivastigmine Transdermal System, a generic version of Novartis’ Exelon Patch, for the treatment of patients suffering from dementia in the US.
Teva Launches Generic Version of Uceris in the United States americanpharmaceuticalreview
July 11, 2018
Teva announced the launch of a generic version of Uceris (budesonide) extended-release tablets, 9 mg, in the U.S.
Perrigo Confirms First To File Patent Challenge for Generic Version of Ultravate Lotion, 0.05% americanpharmaceuticalreview
May 18, 2018
Perrigo announced that Sun Pharmaceutical and MiCal Pharmaceuticals initiated patent litigations on May 9 and 10, 2018, in the U.S. District Court for the District of Delaware
Perrigo Launches Generic Version of Axiron americanpharmaceuticalreview
July 06, 2017
Perrigo Company announced the prescription pharmaceutical launch of testosterone topical solution, 30 mg/1.5 mL (CIII), the generic equivalent to Eli Lilly and Company's Axiron Topical Solution, 30 mg/1.5 mL (CIII).

Previous page 1 2 Next page